Needham, Massachusetts (PRWEB) June 20, 2012
Cambridge Healthtech Associates™ (CHA™) is pleased to announce that it is co-sponsoring Xconomy’s BIO Debrief Networking Reception on Thursday, June 21st.
The BIO Debrief Reception is an opportunity for a select group of biotech CEOs, investors and innovators to discuss relevant issues from the BIO International Convention in Boston this week.
“As the industry-leading organization in life sciences drug discovery, when it comes to collaborative projects and technology evaluations, we are looking to find new places where we can bring our collaborative methodologies and contractual agreements with numerous biopharma companies -- to new industry-wide issues. We are pleased to be co-sponsoring this networking reception with Xconomy and look forward to learning which issues strike a chord with our guests,” said Dawn Van Dam, General Manager of Cambridge Healthtech Associates.
About Cambridge Healthtech Associates (CHA)
Cambridge Healthtech Associates™ (CHA™) uses its unique collaborative model to improve the speed, economics and effectiveness of life science research and development, leveraging its consulting, technology evaluations and communities to help clients in the industry achieve their individual goals. Read more at http://www.chacorporate.com.
Cambridge Healthtech Associates organizes two online communities: NGS Leaders™ (http://www.ngsleaders.org) is an online community for people working in next-generation sequencing, genomics, bioinformatics and the Drug Safety Executive Council™ (http://www.drugsafetycouncil.org), an online community focused on the development of better and safer medicines.
Copyright©2012 Vocus, Inc.
All rights reserved